The U.S. Food and Drug Administration is unlikely to ask its outside vaccine advisers to weigh in on whether the agency should authorize Pfizer COVID-19 boosters for all adults, CNN reported on Friday, citing a source.
A nurses fills up syringes for patients as they receive their coronavirus disease booster vaccination during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, U.S., September 29, 2021. REUTERS/Emily Elconin
Nov 12 - The U.S. Food and Drug Administration is unlikely to ask its outside vaccine advisers to weigh in on whether the agency should authorize PfizerThe source told CNN "it's unlikely there is going to be a meeting" of the outside advisers and "there has been no discussion of a meeting" to discuss Pfizer's application.
The FDA said the agency "will determine whether to hold a meeting of the advisory committee ... following its initial review of the information submitted," CNNPfizer and BioNTech on Tuesday requested the FDA to authorize booster doses of their COVID-19 vaccine in all adults, presenting data showing the shot would help prevent disease across ages.
Pfizer previously requested authorization for all people aged 16 or over, but the FDA held back on extending boosters to everyone, partly because there was not enough evidence of waning immunity or of the benefit of boosters in younger people. U.S. President Joe Biden's administration in August announced plans to roll out booster doses for all adults in September, before the FDA's advisers had recommended a limited authorization.More from ReutersSubscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Germany mulls new COVID-19 measures as infections spikeGermany’s national disease control center has reported a record-high number of more than 50,000 daily coronavirus cases.
Les mer »
Africans with diabetes at higher risk of Covid-19 related deathAfrica is expected to reach up to 55 million diabetes cases by 2045, more than double its current numbers and well beyond the rest of the world
Les mer »
COVID-19 hot spots offer sign of what could be ahead for USThe delta variant is driving up COVID-19 hospitalizations in the Mountain West and fueling outbreaks in the North. It's a worrisome sign of what could be ahead this winter in the U.S. Trends are improving in Florida, Texas and other Southern states.
Les mer »
COVID-19 live updates: Hospitalizations on the rise in 14 statesLATEST: Colorado Gov. Jared Polis signs executive order declaring the entire state at high risk from COVID-19, thereby making all fully vaccinated adults eligible to receive a booster shot.
Les mer »
Federal appeals court keeps on hold Biden's COVID-19 vaccine-or-testing rule for large companiesThe legal fight over Biden's vaccine-or-testing mandate for large companies is being waged over whether OSHA's powers extend to battling a virus.
Les mer »